Ultomiris-exposed pregnant/ postpartum

Clinical trials for Ultomiris-exposed pregnant/ postpartum explained in plain language.

Never miss a new study

Get alerted when new Ultomiris-exposed pregnant/ postpartum trials appear

Sign up with your email to follow new studies for Ultomiris-exposed pregnant/ postpartum, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New study tracks safety of ultomiris in pregnant women

Knowledge-focused Recruiting now

This study follows 75 pregnant women who have taken Ultomiris (ravulizumab) for conditions like PNH or aHUS. Researchers will track pregnancy outcomes and baby health up to one year after birth. The goal is to gather safety information, not to test a new treatment.

Matched conditions: ULTOMIRIS-EXPOSED PREGNANT/ POSTPARTUM

Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Knowledge-focused

Last updated Jun 27, 2026 12:07 UTC

Ultomiris-exposed pregnant/ postpartum

Get alerted when new Ultomiris-exposed pregnant/ postpartum trials appear

New study tracks safety of ultomiris in pregnant women